Off Patent
July 2027

Pristiq

desvenlafaxine succinate

PF Prism CV

Tablet, extended release (oral) · NDA 021992

Last listed protection ends
July 5, 2027

The FDA lists 1 patent for Pristiq, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 8,269,040
    Claims the drug substance